Cosan (CSAN3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
2 Jul, 2026Executive summary
2024 began with optimism for rate cuts, but inflation and debt concerns led to higher rates and a tougher macro environment in Brazil, impacting results.
Strong operational results in most portfolio companies, except for Raízen, which underperformed and underwent management restructuring.
Major portfolio moves included asset sales (notably the Vale stake in January 2025), acquisitions, and strategic partnerships across Compass, Moove, Rumo, Radar, and Raízen.
Management emphasized capital discipline, deleveraging, and portfolio quality, with proceeds from asset sales directed to debt reduction.
Reported unaudited Q4 and full-year 2024 results, with audited numbers expected by March 10th; no material changes anticipated.
Financial highlights
Consolidated net revenue reached R$44.0 billion in 2024, up 11% year-over-year.
EBITDA under management was R$30.0 billion in 2024 (down from R$32.1 billion in 2023); reported EBITDA was R$15.7 billion, down from R$20.0 billion.
Net loss for 2024 was R$9.4 billion, mainly due to impairments on Vale (R$4.7 billion), Rumo Malha Sul (R$3.1 billion), and deferred tax provisions.
Dividends and interest on capital received in 2024 totaled R$4.3 billion, up 24% YoY, primarily due to Compass resuming payments.
Corporate net debt at year-end stood at R$23.5 billion, up from R$21.7 billion in 3Q24.
Outlook and guidance
2025 will focus on capital allocation discipline, deleveraging, and supporting value creation in portfolio companies, with more transactions expected to reduce leverage.
Management targets a Debt Service Coverage Ratio (DSCR) of at least 1.5x, up from 1.1x at year-end 2024.
Proceeds from Vale stake sale are being used for debt prepayment and capital structure optimization.
Latest events from Cosan
- EBITDA and net income fell, but major asset sales and capital raises improved leverage and liquidity.CSAN3
Q4 20259 Jul 2026 - Net loss reached R$1.8B, EBITDA fell 30%, but net debt dropped to R$17.5B after asset sales.CSAN3
Q1 20258 Jul 2026 - EBITDA rose, net income fell, and management changes and acquisitions shaped the quarter.CSAN3
Q3 20242 Jul 2026 - EBITDA rose 15% to R$7.1bn, net loss narrowed, and capital discipline remained strong.CSAN3
Q2 20242 Jul 2026 - Net loss narrowed to R$1.6 billion, with strong EBITDA and major deleveraging actions.CSAN3
Q1 202622 May 2026 - EBITDA and net income declined, but R$10.5 billion equity raised improved capital structure.CSAN3
Q3 20253 Feb 2026 - EBITDA fell to R$6.0bn, net loss widened, and leverage rose to 3.4x as segment results diverged.CSAN3
Q2 20253 Feb 2026